Table of Contents

2019-2024 Global Carmustine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Carmustine Consumption 2014-2024
  • 2.1.2 Carmustine Consumption CAGR by Region
• 2.2 Carmustine Segment by Type
  • 2.2.1 100mg Injection
  • 2.2.2 125mg Injection
• 2.3 Carmustine Consumption by Type
  • 2.3.1 Global Carmustine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Carmustine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Carmustine Sale Price by Type (2014-2019)
• 2.4 Carmustine Segment by Application
  • 2.4.1 Glioma
  • 2.4.2 Glioblastoma Multiforme
  • 2.4.3 Medulloblastoma and Astrocytoma
  • 2.4.4 Multiple Myeloma
  • 2.4.5 Lymphoma
  • 2.4.6 Other
• 2.5 Carmustine Consumption by Application
  • 2.5.1 Global Carmustine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Carmustine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Carmustine Sale Price by Application (2014-2019)

3 Global Carmustine by Manufacturers

• 3.1 Global Carmustine Sales Market Share by Manufacturers
  • 3.1.1 Global Carmustine Sales by Manufacturers (2017-2019)
  • 3.1.2 Global Carmustine Sales Market Share by Manufacturers (2017-2019)
• 3.2 Global Carmustine Revenue Market Share by Manufacturers
  • 3.2.1 Global Carmustine Revenue by Manufacturers (2017-2019)
  • 3.2.2 Global Carmustine Revenue Market Share by Manufacturers (2017-2019)
• 3.3 Global Carmustine Sale Price by Manufacturers
• 3.4 Global Carmustine Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
  • 3.4.1 Global Carmustine Manufacturing Base Distribution and Sales Area by Manufacturers
  • 3.4.2 Players Carmustine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Carmustine by Regions

• 4.1 Carmustine by Regions
  • 4.1.1 Global Carmustine Consumption by Regions
  • 4.1.2 Global Carmustine Value by Regions
• 4.2 Americas Carmustine Consumption Growth
• 4.3 APAC Carmustine Consumption Growth
• 4.4 Europe Carmustine Consumption Growth
• 4.5 Middle East & Africa Carmustine Consumption Growth

5 Americas

• 5.1 Americas Carmustine Consumption by Countries
  • 5.1.1 Americas Carmustine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Carmustine Value by Countries (2014-2019)
• 5.2 Americas Carmustine Consumption by Type
• 5.3 Americas Carmustine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Carmustine Consumption by Countries
  • 6.1.1 APAC Carmustine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Carmustine Value by Countries (2014-2019)
• 6.2 APAC Carmustine Consumption by Type
• 6.3 APAC Carmustine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Carmustine by Countries
  • 7.1.1 Europe Carmustine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Carmustine Value by Countries (2014-2019)
• 7.2 Europe Carmustine Consumption by Type
• 7.3 Europe Carmustine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Carmustine by Countries
  • 8.1.1 Middle East & Africa Carmustine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Carmustine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Carmustine Consumption by Type
• 8.3 Middle East & Africa Carmustine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Carmustine Distributors
• 10.3 Carmustine Customer

11 Global Carmustine Market Forecast

• 11.1 Global Carmustine Consumption Forecast (2019-2024)
• 11.2 Global Carmustine Forecast by Regions
  • 11.2.1 Global Carmustine Forecast by Regions (2019-2024)
  • 11.2.2 Global Carmustine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Carmustine Forecast by Type
• 11.8 Global Carmustine Forecast by Application

12 Key Players Analysis

• 12.1 Amneal Pharms
  • 12.1.1 Company Details
  • 12.1.2 Carmustine Product Offered
  • 12.1.3 Amneal Pharms Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Amneal Pharms News
• 12.2 Arbor Pharms
  • 12.2.1 Company Details
  • 12.2.2 Carmustine Product Offered
  • 12.2.3 Arbor Pharms Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Arbor Pharms News
• 12.3 Emcure Pharms
  • 12.3.1 Company Details
  • 12.3.2 Carmustine Product Offered
  • 12.3.3 Emcure Pharms Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Emcure Pharms News
• 12.4 Navinta
  • 12.4.1 Company Details
  • 12.4.2 Carmustine Product Offered
  • 12.4.3 Navinta Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Navinta News
• 12.5 STI Pharma
  • 12.5.1 Company Details
  • 12.5.2 Carmustine Product Offered
  • 12.5.3 STI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 STI Pharma News
• 12.6 Obvius Pharmaceuticals
  • 12.6.1 Company Details
  • 12.6.2 Carmustine Product Offered
  • 12.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Obvius Pharmaceuticals News
• 12.7 MGI Pharma
  • 12.7.1 Company Details
  • 12.7.2 Carmustine Product Offered
  • 12.7.3 MGI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 MGI Pharma News
• 12.8 Marcan Pharmaceuticals
  • 12.8.1 Company Details
  • 12.8.2 Carmustine Product Offered
  • 12.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Marcan Pharmaceuticals News
• 12.9 Eisai
  • 12.9.1 Company Details
  • 12.9.2 Carmustine Product Offered
  • 12.9.3 Eisai Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Eisai News
• 12.10 Bristol-Myers Squibb
  • 12.10.1 Company Details
  • 12.10.2 Carmustine Product Offered
  • 12.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Bristol-Myers Squibb News
• 12.11 Pharmaplan
• 12.12 Sanli Ilac
• 12.13 Zydus Pharmaceuticals
• 12.14 Tianjin Kingyork

13 Research Findings and Conclusion

According to this study, over the next five years the Carmustine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Carmustine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Carmustine market by product type, application, key manufacturers and key regions and countries.

This study considers the Carmustine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
100mg Injection
125mg Injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Glioma
Glioblastoma Multiforme
Medulloblastoma and Astrocytoma
Multiple Myeloma
Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amneal Pharms
Arbor Pharms
Emcure Pharms
Navinta
STI Pharma
Obvius Pharmaceuticals
MGI Pharma
Marcan Pharmaceuticals
Eisai
Bristol-Myers Squibb
Pharmaplan
Sanli Ilac
Zydus Pharmaceuticals 
Tianjin Kingyork

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Carmustine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Carmustine market by identifying its various subsegments.
Focuses on the key global Carmustine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Carmustine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Carmustine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.